The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...

Do not share your Humulin R U-500 KwikPen®or U-500 syringe with anyone. Even if you have changed the needle, you or the other person can get a serious infection. When using the Humulin R U-500 KwikPen ...

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...

Diabetes is a disease that causes high blood sugar levels. Not treating your high blood sugar levels can damage your heart and blood vessels. It can also lead to stroke, kidney failure, and blindness.

The US Food and Drug Administration (FDA) has approved the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen [insulin human injection] 500 units/mL, ...

Diabetes is a condition in which your body stops reacting to or creating insulin. One of insulin’s jobs is to move sugar from your blood into your cells, which use sugar for energy. With too little ...

The active ingredient in Humulin N is NPH insulin. (An active ingredient is what makes a drug work.) Humulin N comes as a suspension (a type of liquid mixture) that you inject under your skin. It’s ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

Please provide your email address to receive an email when new articles are posted on . The European Medicine Agency’s Committee for Medicinal Products for Human Use recommended approval of Eli Lilly ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...